Pall Files Patent Infringement Suit Against BioQuate

Pall Corporation (NYSE:PLL) filed a patent infringement action in
the United States District Court for the Eastern District of
Pennsylvania against BioQuate, Inc., based in Clearwater, Florida. The
suit alleges that BioQuate is manufacturing and selling disposable
aseptic connector devices that infringe on a patent on Pall's
KleenpakTM Aseptic Connector. The suit seeks damages and an injunction
precluding BioQuate from selling the infringing product.

Pall is a leading provider of integrated filtration solutions to
the biopharmaceutical industry and has spearheaded the development of
single-use technologies for biopharmaceutical processing. Pall's
Kleenpak Aseptic Connector has been established as the leading aseptic
connection device and is an enabling technology that improves the
safety and efficiency of single-use processing.

Pall's proprietary materials and technologies along with the
ability to engineer them into useful forms are the cornerstone of the
Company's technical and marketing leadership. Pall Corporation
vigorously protects its intellectual property rights. It respects the
intellectual property rights of others and expects the same in return.

About Pall Corporation:

Pall Corporation is the global leader in the rapidly growing field
of filtration, separation and purification. Pall is organized into two
businesses: Life Sciences and Industrial. These businesses provide
leading-edge products to meet the demanding needs of customers in
biotechnology, pharmaceutical, transfusion medicine, energy,
electronics, municipal and industrial water purification, aerospace,
transportation and broad industrial markets. Total revenues for fiscal
year 2006 were $2.0 billion. The Company headquarters is in East
Hills, New York with extensive operations throughout the world. For
more information visit Pall at http://www.pall.com/.

Forward Looking Statements

Forward-looking statements contained in this and other written and
oral reports are based on current Company expectations and are subject
to risks and uncertainties, which could cause actual results to differ
materially. All statements regarding future performance, earnings
projections, earnings guidance, events or developments are
forward-looking statements. Such risks and uncertainties include, but
are not limited to: changes in product mix and product pricing
particularly as we expand our systems business in which we experience
significantly longer sales cycles and less predictable revenue with no
certainty of future revenue streams from related consumable product
offerings and services; increases in costs of manufacturing and
operating costs including energy and raw materials; the Company's
ability to achieve the savings anticipated from cost reduction and
margin improvement initiatives including the timing of completion of
the facilities rationalization initiative; fluctuations in foreign
currency exchange rates and interest rates; regulatory approval and
market acceptance of new technologies; changes in business
relationships with key customers and suppliers including delays or
cancellations in shipments; success in enforcing patents and
protecting proprietary products and manufacturing techniques;
successful completion or integration of acquisitions; domestic and
international competition in the Company's global markets; and global
and regional economic conditions and legislative, regulatory and
political developments. The Company makes these statements as of the
date of this disclosure and undertakes no obligation to update them.